Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products, 21787-21790 [2019-09997]
Download as PDF
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
Dated: May 10, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
AGENCY:
emerging models of integrated health
care.
Program Name: Enhancing the
Knowledge and Skills of the Aging
Network.
Recipient: Meals on Wheels America.
Period of Performance: The
supplement award will be issued for the
second year of a three year project
period of Sept 1, 2017 to August 31,
2020.
Total Award Amount: $482,390 in FY
2019.
Award Type: Cooperative Agreement
Supplement.
Statutory Authority: The Older
Americans Act (OAA) of 1965, as
amended, Public Law 114–144.
The Administration for
Community Living is announcing its
intent to Award a Single-Source
Supplement to provide the National
Aging Network with timely, relevant,
high quality opportunities to further
enhance their knowledge and skills
related to nutrition services.
FOR FURTHER INFORMATION CONTACT: For
further information or comments
regarding this program supplement,
contact Keri Lipperini, U.S. Department
of Health and Human Services,
Administration for Community Living,
Administration on Aging, Office of
Nutrition and Health Promotion
Programs, 202–795–7422, email
keri.lipperini@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Administration for Community Living
(ACL) announces the intent to award a
single-source supplement to the current
cooperative agreement held by Meals on
Wheels America for the project
Enhancing the Knowledge and Skills of
the Aging Network. The purpose of this
supplement is to: (1) Support the
development and dissemination of
resources for experienced and
inexperienced Aging Network Nutrition
Program providers; and (2) enhance
peer-learning opportunities for State
Units on Aging (SUAs), Area Agencies
on Aging (AAAs), and Nutrition
Program providers.
The administrative supplement for FY
2019 will be in the amount of $257,401,
bringing the total award for FY 2019 to
$482,390.
The additional funding will not be
used to begin new projects, but it will
be used to enhance existing efforts. The
grantee will continue to provide
appropriate, quality nutrition-related
resources, address new opportunities to
embed nutrition services within the
home and community-based service
systems, and engage successfully in
Basis for Award
Meals on Wheels America (MOWA) is
currently funded to carry out the
objectives of this project through its
current project entitled, National
Resource Center on Nutrition and Aging
for the period of September 1, 2017
through August 31, 2020. Since the
project’s implementation, the grantee
has made satisfactory progress toward
its approved work plan. The
supplement will enable the grantee to
carry their work even further, enhancing
the support they provide to the Aging
Network Nutrition Program Providers.
The additional funding will not be used
to begin new projects or activities, but
rather to continue to enhance efforts
specific to tribal populations and
congregate meal settings.
MOWA is uniquely positioned to
complete the work called for under this
project. They have an already
established infrastructure and are a
known and trusted organization in the
Aging Network. They have an
established presence within much of the
Aging Network. Under this current
award period, they are providing
educational opportunities for the Aging
Network Nutrition Program Providers,
including webinars and live trainings.
They have a comprehensive, interactive
web-based repository
(www.nutritionandaging.org) with tools
and resources, including—but not
limited to—issues briefs, policy and
practice models, and toolkits. They have
also presented to the Aging Network
locally and on a national level. They
have reached thousands of providers
using their: (1) Comprehensive database
of SUAs, AAAs, and other Nutrition
Program Providers; and (2) Leadership
Academy, which provides expert
consultation around nutrition program
delivery and the use of technology to
enhance services. In addition, they have
developed partnerships with
organizations, universities, and other
[FR Doc. 2019–09998 Filed 5–14–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HELATH AND
HUMAN SERVICES
Administration for Community Living
Intent To Award a Single-Source
Supplement to the National Aging
Network
Administration for Community
Living, HHS.
ACTION: Notice.
jbell on DSK3GLQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
21787
entities to provide education and
support for the Aging Network.
Establishing an entirely new grant
project at this time would be potentially
disruptive to the current work already
well under way. More importantly, it
could cause confusion among the Aging
Network Nutrition Program Providers,
which could have a negative effect on
training and support opportunities. If
this supplement were not provided, the
project would be unable to address the
significant unmet educational needs of
the Aging Network Nutrition Program
Providers.
Dated: May 9, 2019.
Mary Lazare,
Principal Deputy Administrator .
[FR Doc. 2019–10029 Filed 5–14–19; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0386]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Registration and
Product Listing for Owners and
Operators of Domestic Tobacco
Product Establishments and Listing of
Ingredients in Tobacco Products
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(PRA).
SUMMARY:
Fax written comments on the
collection of information by June 14,
2019.
DATES:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0650. Also
include the FDA docket number found
in brackets in the heading of this
document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
E:\FR\FM\15MYN1.SGM
15MYN1
21788
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Registration and Product Listing for
Owners and Operators of Domestic
Tobacco Product Establishments and
Listing of Ingredients in Tobacco
Products
jbell on DSK3GLQ082PROD with NOTICES
OMB Control Number 0910–0650—
Extension
On June 22, 2009, the Family
Smoking Prevention and Tobacco
Control Act (Tobacco Control Act) (Pub.
L. 111–31) was signed into law. The
Tobacco Control Act amended the
Federal Food, Drug, and Cosmetic Act
(FD&C Act) by adding, among other
things, a chapter granting FDA
important authority to regulate the
manufacture, marketing, and
distribution of tobacco products to
protect the public health generally and
to reduce tobacco use by minors. The
Tobacco Control Act created new
requirements for the tobacco industry.
Section 101 of the Tobacco Control Act
amended the FD&C Act by adding
sections 905 and 904 (21 U.S.C. 387e
and 387d).
Section 905 of the FD&C Act requires
the annual registration of any
‘‘establishment in any State engaged in
the manufacture, preparation,
compounding, or processing of a
tobacco product or tobacco products.’’
Section 905 requires this registration be
completed by December 31 of each year.
The Secretary of Health and Human
Services (Secretary) has delegated to the
Commissioner of Food and Drugs the
responsibility for administering the
FD&C Act, including section 905.
Section 905 of the FD&C Act requires
owners or operators of each
establishment to register: (1) Their
name; (2) places of business; (3) a list of
all tobacco products that are
manufactured by that person; (4) a copy
of all labeling and a reference to the
authority for the marketing of any
tobacco product subject to a tobacco
product standard under section 907 of
the FD&C Act (21 U.S.C. 387g) or to
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
premarket review under section 910 of
the FD&C Act (21 U.S.C. 387j); (5) a
copy of all consumer information and
other labeling; (6) a representative
sampling of advertisements; (7) upon
request made by the Secretary for good
cause, a copy of all advertisements for
a particular tobacco product; and (8)
upon request made by the Secretary, if
the registrant has determined that a
tobacco product contained in the
product list is not subject to a tobacco
product standard established under
section 907 of the FD&C Act, a brief
statement of the basis upon which the
registrant made such determination.
FDA collects the information
submitted pursuant to section 905 of the
FD&C Act through an electronic portal,
and through paper forms (Forms FDA
3741 and FDA 3741a) for those
individuals who choose not to use the
electronic portal.
FDA has also published a guidance
for industry entitled ‘‘Registration and
Product Listing for Owners and
Operators of Domestic Tobacco Product
Establishments’’ (https://www.fda.gov/
downloads/TobaccoProducts/Labeling/
RulesRegulationsGuidance/
UCM191940.pdf). This guidance is
intended to assist persons making
tobacco product establishment
registration and product listing
submissions to FDA.
Section 904(a)(1) of the FD&C Act
requires that each tobacco product
manufacturer or importer submit ‘‘a
listing of all ingredients, including
tobacco, substances, compounds, and
additives that are, as of such date, added
by the manufacturer to the tobacco,
paper, filter, or other part of each
tobacco product by brand and by
quantity in each brand and subbrand’’
by December 22, 2009. This section
applies only to those tobacco products
manufactured and distributed before
June 22, 2009, and which are still
manufactured as of the date of the
ingredient listing submission.
Section 904(c) of the FD&C Act
requires that a tobacco product
manufacturer: (1) Provide all
information required under section
904(a) of the FD&C Act to FDA ‘‘at least
90 days prior to the delivery for
introduction into interstate commerce of
a tobacco product not on the market on
the date of enactment’’ of the Tobacco
Control Act; (2) advise FDA in writing
at least 90 days prior to adding any new
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
tobacco additive or increasing in
quantity an existing tobacco additive,
except for those additives that have
been designated by FDA through
regulation as not a human or animal
carcinogen, or otherwise harmful to
health under intended conditions of
use; and (3) advise FDA in writing at
least 60 days prior to eliminating or
decreasing an existing additive, or
adding or increasing an additive that
has been designated by FDA through
regulation as not a human or animal
carcinogen, or otherwise harmful to
health under intended conditions of
use.
FDA collects the information
submitted pursuant to sections 904(a)(1)
and (c) of the FD&C Act through an
electronic portal, and through a paper
form (Form FDA 3742) for those
individuals who choose not to use the
electronic portal.
In addition to the development of the
electronic portal and paper form, FDA
published a guidance entitled ‘‘Listing
of Ingredients in Tobacco Products.’’
This guidance is intended to assist
persons making tobacco product
ingredient listing submissions. FDA also
provides a technical guide, embedded
hints, and a web tutorial to the
electronic portal.
The Tobacco Control Act also gave
FDA the authority to issue a regulation
deeming all other products that meet the
statutory definition of a tobacco product
to be subject to chapter 9 of the FD&C
Act (section 901(b) (21 U.S.C. 387a(b)).
On May 10, 2016, FDA issued that rule,
extending FDA’s tobacco product
authority to all products that meet the
definition of tobacco product in the law
(except for accessories of newly
regulated tobacco products), including
electronic nicotine delivery systems,
cigars, hookah, pipe tobacco, nicotine
gels, dissolvables that were not already
subject to the FD&C Act, and other
tobacco products that may be developed
in the future (81 FR 28974 at 28976)
(‘‘the final deeming rule’’).
In the Federal Register of October 23,
2018 (83 FR 53478), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. Two comments were
received; however, neither were PRA
related.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\15MYN1.SGM
15MYN1
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
21789
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Tobacco Product Establishment Initial Registration and Listing; Form FDA 3741 Registration
and Product Listing for Owners and Operators
of Domestic Establishments (Electronic and
Paper submissions); Section 905(b), (c), (d),
(h), or (i).
Tobacco Product Establishment Renewal Registration and Listing; Form FDA 3741 Registration and Product Listing for Owners and
Operators of Domestic Establishments (Electronic and Paper submissions); Section
905(b), (c), (d), (h), or (i).
Tobacco Product Listing; Form FDA 3742 Listing of Ingredients (Electronic and Paper submissions); Section 904(a)(1).
Tobacco Product Listing; Form FDA 3742 Listing of Ingredients (Electronic and Paper submissions); Section 904(c).
Obtaining a Dun and Bradstreet D–U–N–S
Number.
Total .............................................................
jbell on DSK3GLQ082PROD with NOTICES
1 There
Number of
responses per
respondent
Number of
respondents
FDA form/activity/FD&C act section
Average
burden per
response
Total annual
responses
Total hours
100
1
100
1.6 ..................................
160
3,578
1
3,578
0.16 (10 minutes) ...........
572
10
1
10
2 .....................................
20
35
2
70
0.40 (24 minutes) ...........
28
100
1
100
0.5 (30 minutes) .............
50
........................
........................
........................
........................................
830
are no capital costs or operating and maintenance costs associated with this collection of information.
The PRA burden estimates have been
updated to fully incorporate the use of
an electronic system known as FURLS
for submitting registration and product
listing information to FDA. With the
FURLS, manufacturers can enter
information quickly and easily. For
example, product label pictures can be
uploaded directly. We anticipate that
most, if not all companies, already have
electronic versions of their labels for
printing, sales, or marketing purposes.
Product listing information is
provided at the time of registration.
Currently, registration and listing
requirements only apply to domestic
establishments engaged in the
manufacture, preparation,
compounding, or processing of a
tobacco product. This includes
importers to the extent that they engage
in the manufacture, preparation,
compounding, or processing of a
tobacco product, including repackaging
or otherwise changing the container,
wrapper, or labeling of any tobacco
product package. Foreign
establishments are not required to
register and list until FDA issues
regulations establish such requirements
in accordance with section 905(h) of the
FD&C Act. To account for the foregoing,
we include both domestic
manufacturing establishments and
importers in our estimates.
Because the deadline for initial
establishment registration and product
listing for both statutorily regulated and
deemed products has passed, FDA
estimates that few (up to 100) new
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
establishments will submit 1 initial
establishment registration and product
listing report each year. Such new
establishments potentially include new
vape shop locations that mix or
assemble products on the market as of
the final deeming rule effective date.
The Agency estimates that up to 100
tobacco establishments will each submit
1 initial establishment registration and
product listing report each year, which
is expected to take 1.6 hours, for a total
160 burden hours.
FDA estimates that the confirmation
or updating of establishment registration
and product listing information as
required by section 905 of the FD&C Act
will take 10 minutes annually per
confirmation or update per
establishment. Based on FDA’s
experience with current establishment
registration and product listings
submitted to the Agency, the Agency
estimates that on average 3,578
establishments will each submit 1
confirmation or updated report each
year, which is expected to take 0.16
hour (10 minutes) for a total 572 burden
hours.
FDA estimates that we have received
most tobacco product ingredient
submissions for large manufacturers of
deemed products. Small manufacturers’
deadline for ingredient submissions is
November 2018. This is based on the
counts we have to date (July 2018),
including statutorily regulated products
(based on information in our tracking
system).
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
FDA estimates that the submission of
ingredient listings required by section
904(a)(1) of the FD&C Act for each
establishment will take 2 hours initially.
Because this burden estimate covers a
timeframe of 3 years, we anticipate
almost all section 904(a)(1) tobacco
ingredient submissions to have been
received before the expiration of the
current approval (prior to November 8,
2018, for small manufacturers and for
large manufacturers, May 8, 2018). We
are estimating approximately 30
manufacturers may miss their deadline.
This is based on estimates of how many
large manufacturers we are aware of that
have missed their deadline. Because this
burden estimate covers 3 years, we are
dividing by 3, to yield 10 respondents
as a yearly average for this estimate.
Therefore, FDA estimates that 10
establishments will initially submit 1
report annually at 2 hours per report, for
a total of 20 hours.
Submissions under 904(c) of the
FD&C Act are for any new product that
is not yet on the market (e.g., if on the
market due to deeming compliance
period); newly deemed product
manufacturers should have submitted
under section 904(a)(1) of the FD&C Act.
This includes any statutorily regulated
product that would receive a marketing
authorization and any new deemed
product not subject to the deeming
compliance period. For deemed product
categories, while we anticipate receiving
a large number of premarket
applications, there is a portion of these
applicants who will have reported their
E:\FR\FM\15MYN1.SGM
15MYN1
21790
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
ingredients under section 904(a)(1) as
most of these submissions are expected
to be for products subject to the
deeming compliance period.
Based on FDA’s experience and the
actual number of product ingredient
listings submitted over the past 3 years,
FDA estimates that 35 establishments
will each submit 2 reports (1 every 6
months). FDA also estimates that the
confirmation or updating of product
(ingredient) listing information required
by section 904(c) of the FD&C Act is
expected to take 0.40 hour (24 minutes)
and will take 48 minutes annually for
two confirmations or updates per
establishment, for a total 28 burden
hours. FDA estimates that obtaining a
DUNS (data universal numbering
system) number will take 30 minutes.
FDA assumes that all new establishment
facilities that will be required to
initially register under section 905 of
the FD&C Act would obtain a DUNS
number. FDA estimates that up to 100
establishments would need to obtain
this number each year. The total
industry burden to obtain a DUNS
number is 50 hours.
FDA estimates the total burden for
this collection to be 830 hours. We have
adjusted our burden estimate, which has
resulted in a decrease of 93,086 hours to
the currently approved burden. Based
on data we reviewed from the past 3
years and projecting the number of
remaining establishments that have not
registered and submitted product
ingredient listings, we revised the
number of respondents and burden
hours in this information collection.
Dated: May 9, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–09997 Filed 5–14–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jbell on DSK3GLQ082PROD with NOTICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; Information Collection
Request Title: HRSA Ryan White HIV/
AIDS Program AIDS Education and
Training Centers Evaluation Activities,
OMB No. 0915–0281—Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
ACTION:
Notice.
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than June 14, 2019.
ADDRESSES: Submit your comments,
including the ICR Title, to the desk
officer for HRSA, either by email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer, at
paperwork@hrsa.gov or call (301) 443–
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
HRSA Ryan White HIV/AIDS Program
AIDS Education and Training Centers
Evaluation Activities: (OMB No. 0915–
0281) Revision.
Abstract: The RWHAP AETC
program, authorized by Title XXVI of
the Public Health Service Act, supports
a network of regional and national
centers that conduct targeted,
multidisciplinary education and
training programs for health care
providers serving people living with
HIV (PLWH). The purpose of the
RWHAP AETC program is to increase
the size and strengthen the skills of the
current and novice HIV clinical
workforce in the United States and to
develop and disseminate information on
treatment and prevention of HIV to atrisk populations. Through the provision
of specialized professional education
and training, the RWHAP Regional
AETCs aim to improve outcomes along
the HIV care continuum including
diagnosis, linkage, retention, and viral
suppression and to reduce HIV
incidence by improving the
achievement and maintenance of viral
load suppression of PLWH. In addition,
the RWHAP AETC program includes the
National Coordinating Resource Center
(NCRC), which offers a virtual library of
online training resources for adaptation
by HIV care providers and other
healthcare professionals to meet local
training needs. The RWHAP AETC
NCRC works closely with the HRSA
HIV/AIDS Bureau (HAB) to coordinate
cross-regional collaborative efforts,
manage the NCRC website, plan and
execute the national RWHAP Clinical
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Conference, and develop an online
curriculum for clinical learners.
The RWHAP AETC proposes several
revisions to the Event Records (ER) and
the Participant Information Form (PIF).
The ER will have 11 new data elements;
however, only 7 data elements will
require responses from all respondents.
The option to respond to the other four
data elements will depend on how
participants respond to previous
questions. There are four data element
deletions to the ER.
The PIF will have one new data
element that asks whether respondents
prescribe antiretroviral therapy to their
patients. Two data elements were
deleted. These revisions reflect changes
in the National AETC program guidance
on reporting sources of funding and
multi-session events.
Despite a net increase of eight data
elements across both the ER and PIF
instruments, pilot respondents reported
a decrease in burden. HRSA HAB
modified the data instruments to help
inform the evaluation of AETC
outcomes, improve the logical flow of
questions within each instrument and to
improve the overall clarity of each of the
questions being asked.
A 60-day Federal Register Notice was
published in the Federal Register on
December 18, 2018, vol. 83, No. 242; pp.
64845–47. There were no public
comments.
Need and Proposed Use of the
Information: As part of an ongoing effort
to evaluate RWHAP AETC activities,
information is needed on AETC training
sessions, clinical consultations, and
technical assistance activities. Each
regional center collects information on
RWHAP AETC training events and is
required to report aggregate data on
their activities to HRSA’s HAB. The goal
of national data collection efforts is to
create a uniform set of data elements
that will produce an accurate summary
of the national scope of RWHAP AETC
professional training, consultation, and
events. The elements included in the
national database have been selected for
their relevance in demonstrating the
RWHAP AETCs’ efforts in achieving the
program’s stated goals: To improve care
for PLWH by providing education,
training, and clinical consultation; and
to provide support to clinicians and
other providers. HRSA HAB uses the
data collected when conducting
programmatic assessments and to
determine future program needs. The
national data elements are intended to
be a meaningful core set of elements
that individual RWHAP AETCs can use
in programmatic and strategic planning.
HRSA HAB also uses this information to
E:\FR\FM\15MYN1.SGM
15MYN1
Agencies
[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Pages 21787-21790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09997]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0386]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Registration and
Product Listing for Owners and Operators of Domestic Tobacco Product
Establishments and Listing of Ingredients in Tobacco Products
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995 (PRA).
DATES: Fax written comments on the collection of information by June
14, 2019.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax: 202-395-7285, or emailed to [email protected]. All
comments should be identified with the OMB control number 0910-0650.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations,
[[Page 21788]]
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-8867,
[email protected].
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Registration and Product Listing for Owners and Operators of Domestic
Tobacco Product Establishments and Listing of Ingredients in Tobacco
Products
OMB Control Number 0910-0650--Extension
On June 22, 2009, the Family Smoking Prevention and Tobacco Control
Act (Tobacco Control Act) (Pub. L. 111-31) was signed into law. The
Tobacco Control Act amended the Federal Food, Drug, and Cosmetic Act
(FD&C Act) by adding, among other things, a chapter granting FDA
important authority to regulate the manufacture, marketing, and
distribution of tobacco products to protect the public health generally
and to reduce tobacco use by minors. The Tobacco Control Act created
new requirements for the tobacco industry. Section 101 of the Tobacco
Control Act amended the FD&C Act by adding sections 905 and 904 (21
U.S.C. 387e and 387d).
Section 905 of the FD&C Act requires the annual registration of any
``establishment in any State engaged in the manufacture, preparation,
compounding, or processing of a tobacco product or tobacco products.''
Section 905 requires this registration be completed by December 31 of
each year. The Secretary of Health and Human Services (Secretary) has
delegated to the Commissioner of Food and Drugs the responsibility for
administering the FD&C Act, including section 905. Section 905 of the
FD&C Act requires owners or operators of each establishment to
register: (1) Their name; (2) places of business; (3) a list of all
tobacco products that are manufactured by that person; (4) a copy of
all labeling and a reference to the authority for the marketing of any
tobacco product subject to a tobacco product standard under section 907
of the FD&C Act (21 U.S.C. 387g) or to premarket review under section
910 of the FD&C Act (21 U.S.C. 387j); (5) a copy of all consumer
information and other labeling; (6) a representative sampling of
advertisements; (7) upon request made by the Secretary for good cause,
a copy of all advertisements for a particular tobacco product; and (8)
upon request made by the Secretary, if the registrant has determined
that a tobacco product contained in the product list is not subject to
a tobacco product standard established under section 907 of the FD&C
Act, a brief statement of the basis upon which the registrant made such
determination.
FDA collects the information submitted pursuant to section 905 of
the FD&C Act through an electronic portal, and through paper forms
(Forms FDA 3741 and FDA 3741a) for those individuals who choose not to
use the electronic portal.
FDA has also published a guidance for industry entitled
``Registration and Product Listing for Owners and Operators of Domestic
Tobacco Product Establishments'' (https://www.fda.gov/downloads/TobaccoProducts/Labeling/RulesRegulationsGuidance/UCM191940.pdf). This
guidance is intended to assist persons making tobacco product
establishment registration and product listing submissions to FDA.
Section 904(a)(1) of the FD&C Act requires that each tobacco
product manufacturer or importer submit ``a listing of all ingredients,
including tobacco, substances, compounds, and additives that are, as of
such date, added by the manufacturer to the tobacco, paper, filter, or
other part of each tobacco product by brand and by quantity in each
brand and subbrand'' by December 22, 2009. This section applies only to
those tobacco products manufactured and distributed before June 22,
2009, and which are still manufactured as of the date of the ingredient
listing submission.
Section 904(c) of the FD&C Act requires that a tobacco product
manufacturer: (1) Provide all information required under section 904(a)
of the FD&C Act to FDA ``at least 90 days prior to the delivery for
introduction into interstate commerce of a tobacco product not on the
market on the date of enactment'' of the Tobacco Control Act; (2)
advise FDA in writing at least 90 days prior to adding any new tobacco
additive or increasing in quantity an existing tobacco additive, except
for those additives that have been designated by FDA through regulation
as not a human or animal carcinogen, or otherwise harmful to health
under intended conditions of use; and (3) advise FDA in writing at
least 60 days prior to eliminating or decreasing an existing additive,
or adding or increasing an additive that has been designated by FDA
through regulation as not a human or animal carcinogen, or otherwise
harmful to health under intended conditions of use.
FDA collects the information submitted pursuant to sections
904(a)(1) and (c) of the FD&C Act through an electronic portal, and
through a paper form (Form FDA 3742) for those individuals who choose
not to use the electronic portal.
In addition to the development of the electronic portal and paper
form, FDA published a guidance entitled ``Listing of Ingredients in
Tobacco Products.'' This guidance is intended to assist persons making
tobacco product ingredient listing submissions. FDA also provides a
technical guide, embedded hints, and a web tutorial to the electronic
portal.
The Tobacco Control Act also gave FDA the authority to issue a
regulation deeming all other products that meet the statutory
definition of a tobacco product to be subject to chapter 9 of the FD&C
Act (section 901(b) (21 U.S.C. 387a(b)). On May 10, 2016, FDA issued
that rule, extending FDA's tobacco product authority to all products
that meet the definition of tobacco product in the law (except for
accessories of newly regulated tobacco products), including electronic
nicotine delivery systems, cigars, hookah, pipe tobacco, nicotine gels,
dissolvables that were not already subject to the FD&C Act, and other
tobacco products that may be developed in the future (81 FR 28974 at
28976) (``the final deeming rule'').
In the Federal Register of October 23, 2018 (83 FR 53478), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. Two comments were received; however, neither
were PRA related.
FDA estimates the burden of this collection of information as
follows:
[[Page 21789]]
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
FDA form/activity/FD&C act section Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Tobacco Product Establishment Initial 100 1 100 1.6......................................... 160
Registration and Listing; Form FDA 3741
Registration and Product Listing for
Owners and Operators of Domestic
Establishments (Electronic and Paper
submissions); Section 905(b), (c), (d),
(h), or (i).
Tobacco Product Establishment Renewal 3,578 1 3,578 0.16 (10 minutes)........................... 572
Registration and Listing; Form FDA 3741
Registration and Product Listing for
Owners and Operators of Domestic
Establishments (Electronic and Paper
submissions); Section 905(b), (c), (d),
(h), or (i).
Tobacco Product Listing; Form FDA 3742 10 1 10 2........................................... 20
Listing of Ingredients (Electronic and
Paper submissions); Section 904(a)(1).
Tobacco Product Listing; Form FDA 3742 35 2 70 0.40 (24 minutes)........................... 28
Listing of Ingredients (Electronic and
Paper submissions); Section 904(c).
Obtaining a Dun and Bradstreet D-U-N-S 100 1 100 0.5 (30 minutes)............................ 50
Number.
-------------------------------------------------------------------------------------------------------------
Total................................. .............. .............. .............. ............................................ 830
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
The PRA burden estimates have been updated to fully incorporate the
use of an electronic system known as FURLS for submitting registration
and product listing information to FDA. With the FURLS, manufacturers
can enter information quickly and easily. For example, product label
pictures can be uploaded directly. We anticipate that most, if not all
companies, already have electronic versions of their labels for
printing, sales, or marketing purposes.
Product listing information is provided at the time of
registration. Currently, registration and listing requirements only
apply to domestic establishments engaged in the manufacture,
preparation, compounding, or processing of a tobacco product. This
includes importers to the extent that they engage in the manufacture,
preparation, compounding, or processing of a tobacco product, including
repackaging or otherwise changing the container, wrapper, or labeling
of any tobacco product package. Foreign establishments are not required
to register and list until FDA issues regulations establish such
requirements in accordance with section 905(h) of the FD&C Act. To
account for the foregoing, we include both domestic manufacturing
establishments and importers in our estimates.
Because the deadline for initial establishment registration and
product listing for both statutorily regulated and deemed products has
passed, FDA estimates that few (up to 100) new establishments will
submit 1 initial establishment registration and product listing report
each year. Such new establishments potentially include new vape shop
locations that mix or assemble products on the market as of the final
deeming rule effective date. The Agency estimates that up to 100
tobacco establishments will each submit 1 initial establishment
registration and product listing report each year, which is expected to
take 1.6 hours, for a total 160 burden hours.
FDA estimates that the confirmation or updating of establishment
registration and product listing information as required by section 905
of the FD&C Act will take 10 minutes annually per confirmation or
update per establishment. Based on FDA's experience with current
establishment registration and product listings submitted to the
Agency, the Agency estimates that on average 3,578 establishments will
each submit 1 confirmation or updated report each year, which is
expected to take 0.16 hour (10 minutes) for a total 572 burden hours.
FDA estimates that we have received most tobacco product ingredient
submissions for large manufacturers of deemed products. Small
manufacturers' deadline for ingredient submissions is November 2018.
This is based on the counts we have to date (July 2018), including
statutorily regulated products (based on information in our tracking
system).
FDA estimates that the submission of ingredient listings required
by section 904(a)(1) of the FD&C Act for each establishment will take 2
hours initially. Because this burden estimate covers a timeframe of 3
years, we anticipate almost all section 904(a)(1) tobacco ingredient
submissions to have been received before the expiration of the current
approval (prior to November 8, 2018, for small manufacturers and for
large manufacturers, May 8, 2018). We are estimating approximately 30
manufacturers may miss their deadline. This is based on estimates of
how many large manufacturers we are aware of that have missed their
deadline. Because this burden estimate covers 3 years, we are dividing
by 3, to yield 10 respondents as a yearly average for this estimate.
Therefore, FDA estimates that 10 establishments will initially submit 1
report annually at 2 hours per report, for a total of 20 hours.
Submissions under 904(c) of the FD&C Act are for any new product
that is not yet on the market (e.g., if on the market due to deeming
compliance period); newly deemed product manufacturers should have
submitted under section 904(a)(1) of the FD&C Act. This includes any
statutorily regulated product that would receive a marketing
authorization and any new deemed product not subject to the deeming
compliance period. For deemed product categories, while we anticipate
receiving a large number of premarket applications, there is a portion
of these applicants who will have reported their
[[Page 21790]]
ingredients under section 904(a)(1) as most of these submissions are
expected to be for products subject to the deeming compliance period.
Based on FDA's experience and the actual number of product
ingredient listings submitted over the past 3 years, FDA estimates that
35 establishments will each submit 2 reports (1 every 6 months). FDA
also estimates that the confirmation or updating of product
(ingredient) listing information required by section 904(c) of the FD&C
Act is expected to take 0.40 hour (24 minutes) and will take 48 minutes
annually for two confirmations or updates per establishment, for a
total 28 burden hours. FDA estimates that obtaining a DUNS (data
universal numbering system) number will take 30 minutes. FDA assumes
that all new establishment facilities that will be required to
initially register under section 905 of the FD&C Act would obtain a
DUNS number. FDA estimates that up to 100 establishments would need to
obtain this number each year. The total industry burden to obtain a
DUNS number is 50 hours.
FDA estimates the total burden for this collection to be 830 hours.
We have adjusted our burden estimate, which has resulted in a decrease
of 93,086 hours to the currently approved burden. Based on data we
reviewed from the past 3 years and projecting the number of remaining
establishments that have not registered and submitted product
ingredient listings, we revised the number of respondents and burden
hours in this information collection.
Dated: May 9, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-09997 Filed 5-14-19; 8:45 am]
BILLING CODE 4164-01-P